Fda approves biohaven's nurtec® odt (rimegepant) for prevention: now the first and only migraine medication for both acute and preventive treatment

New haven, conn., may 27, 2021 /prnewswire/ -- biohaven pharmaceutical holding company ltd.

BHVN Ratings Summary

BHVN Quant Ranking